Insufficient scRNA-seq data for expression of MMP21 at single-cell level.
Insufficient scRNA-seq data for expression of MMP21 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 99% | 28.33 | 242 / 245 | 17% | 0.29 | 85 / 502 |
| breast | 98% | 20.67 | 448 / 459 | 10% | 0.18 | 117 / 1118 |
| thymus | 100% | 26.44 | 651 / 653 | 6% | 0.11 | 37 / 605 |
| ovary | 100% | 82.27 | 180 / 180 | 4% | 0.07 | 18 / 430 |
| lung | 97% | 13.92 | 559 / 578 | 7% | 0.16 | 77 / 1155 |
| uterus | 96% | 13.52 | 164 / 170 | 7% | 0.15 | 30 / 459 |
| esophagus | 89% | 14.89 | 1285 / 1445 | 14% | 0.21 | 25 / 183 |
| bladder | 100% | 13.52 | 21 / 21 | 2% | 0.11 | 11 / 504 |
| intestine | 98% | 17.32 | 945 / 966 | 3% | 0.05 | 16 / 527 |
| liver | 100% | 19.23 | 225 / 226 | 1% | 0.02 | 4 / 406 |
| stomach | 95% | 13.30 | 342 / 359 | 5% | 0.11 | 14 / 286 |
| spleen | 100% | 27.10 | 241 / 241 | 0% | 0 | 0 / 0 |
| adrenal gland | 95% | 12.91 | 245 / 258 | 4% | 0.06 | 9 / 230 |
| pancreas | 98% | 16.18 | 320 / 328 | 1% | 0.04 | 2 / 178 |
| adipose | 98% | 15.94 | 1180 / 1204 | 0% | 0 | 0 / 0 |
| kidney | 88% | 12.33 | 78 / 89 | 6% | 0.10 | 56 / 901 |
| brain | 87% | 13.03 | 2304 / 2642 | 4% | 0.07 | 29 / 705 |
| heart | 85% | 14.80 | 735 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 82% | 8.27 | 1090 / 1335 | 0% | 0 | 0 / 0 |
| skin | 77% | 7.98 | 1398 / 1809 | 1% | 0.02 | 5 / 472 |
| muscle | 67% | 5.08 | 534 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 35% | 2.12 | 329 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0002244 | Biological process | hematopoietic progenitor cell differentiation |
| GO_0030198 | Biological process | extracellular matrix organization |
| GO_0060976 | Biological process | coronary vasculature development |
| GO_0030574 | Biological process | collagen catabolic process |
| GO_0061371 | Biological process | determination of heart left/right asymmetry |
| GO_0006508 | Biological process | proteolysis |
| GO_0007368 | Biological process | determination of left/right symmetry |
| GO_0005576 | Cellular component | extracellular region |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0004222 | Molecular function | metalloendopeptidase activity |
| GO_0008270 | Molecular function | zinc ion binding |
| Gene name | MMP21 |
| Protein name | Matrix metalloproteinase-21 (MMP-21) (EC 3.4.24.-) Matrix metallopeptidase 21 |
| Synonyms | |
| Description | FUNCTION: Plays a specialized role in the generation of left-right asymmetry during embryogenesis. May act as a negative regulator of the NOTCH-signaling pathway . Cleaves alpha-1-antitrypsin . . |
| Accessions | A0A494C1E5 A0A494C1J6 ENST00000651977.1 ENST00000651834.1 A0A494C0E5 Q8N119 ENST00000652044.1 ENST00000368808.3 |